Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 2/3 1Phase 1 1

Status

Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 262NETWORK 11NIH 8UNKNOWN 3OTHER_GOV 3INDUSTRY 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1CNS 1

Conditions

Neoplasm Metastasis 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Capecitabine 28apatinib 26Oxaliplatin 24Cisplatin 24tislelizumab 23Gemcitabine 23Irinotecan 19Paclitaxel 18Carboplatin 18Docetaxel 15Bevacizumab 15Fluorouracil 14Drug Therapy 13Cyclophosphamide 11pembrolizumab 10camrelizumab 10Vinorelbine 9Radiation 9S 1 (combination) 8Leucovorin 8Cetuximab 8toripalimab 7sintilimab 7Rituximab 7Erlotinib Hydrochloride 7pyrotinib 6Gefitinib 6Albumin-Bound Paclitaxel 6fludarabine 5anlotinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER_GOV × Radiosurgery × Clear all
NCT07470840 2026-03-24

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Fujian Cancer Hospital

Phase 2 Not yet recruiting
27 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00781209 2008-10-28

The Role of Posterior Fossa Irradiation (PFI) Plus Stereotactic Radiosurgery (SRS) for Cerebellar Metastases

Tel-Aviv Sourasky Medical Center

Phase 2 Unknown
30 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00484978 2007-06-12

Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis

Tel-Aviv Sourasky Medical Center

Phase 2 Unknown
35 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡